Second-site NMR screening and linker design

被引:47
作者
Jahnke, W [1 ]
Flörsheimer, A
Blommers, MJJ
Paris, CG
Heim, J
Nalin, CM
Perez, LB
机构
[1] Novartis Pharma AG, Cent Technol, CH-4002 Basel, Switzerland
[2] Novartis Pharma AG, Oncol Res, CH-4002 Basel, Switzerland
[3] Novartis Pharma AG, Cent Technol, Summit, NJ 07901 USA
[4] Novartis Pharma AG, Oncol Res, Summit, NJ 07901 USA
关键词
D O I
10.2174/1568026033392778
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
One of the prime merits of NMR as a tool for lead finding in drug discovery research is its sensitivity and robustness to detect weak protein-ligand interactions. This sensitivity allows to build up ligands for a given target in a modular way, by a fragment-based approach. In this approach, two ligands are seperately identified which bind to the target protein generally weakly but at adjacent binding sites. In a next step, they are chemically linked to produce a high-affinity ligand. This review discusses methods to detect "second-site" ligands that bind to a protein in the presence of a "first-site" ligand, and methods to elucidate structural details on the spatial orientation of both ligands, so that chemical linkage is based on a large piece of experimental information. Published examples from second-site screening and linker design are summarized, and are complemented by previously unpublished in-house examples.
引用
收藏
页码:69 / 80
页数:12
相关论文
共 50 条
[11]   Second-site suppression of regulatory phosphorylation in Escherichia coli isocitrate dehydrogenase [J].
Chen, RD ;
Grobler, JA ;
Hurley, JH ;
Dean, AM .
PROTEIN SCIENCE, 1996, 5 (02) :287-295
[12]   Second-site prosthetic joint infection in patients with multiple prosthetic joints [J].
Clesham K. ;
Hughes A.J. ;
O’ hEireamhoin S. ;
Fleming C. ;
Murphy C.G. .
European Journal of Orthopaedic Surgery & Traumatology, 2018, 28 (7) :1369-1374
[13]   The yeast ADP/ATP carrier. Mutagenesis and second-site revertants [J].
Nelson, DR .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1996, 1275 (1-2) :133-137
[14]   Identification of second-site mutations that enhance release and spread of vaccinia virus [J].
Katz, E ;
Wolffe, E ;
Moss, B .
JOURNAL OF VIROLOGY, 2002, 76 (22) :11637-11644
[15]   Second-Site Compensatory Mutations of HIV-1 Capsid Mutations [J].
Noviello, Colleen M. ;
Lopez, Claudia S. ;
Kukull, Ben ;
McNett, Henry ;
Still, Amelia ;
Eccles, Jacob ;
Sloan, Rachel ;
Barklis, Eric .
JOURNAL OF VIROLOGY, 2011, 85 (10) :4730-4738
[16]   Demonstration of the in vivo interaction of key cell death regulators by structure-based design of second-site suppressors [J].
Parrish, J ;
Metters, H ;
Chen, L ;
Xue, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (22) :11916-11921
[17]   Genetic analysis of second-site revertants of bacteriophage lambda integrase mutants [J].
Wu, Z ;
Gumport, RI ;
Gardner, JF .
JOURNAL OF BACTERIOLOGY, 1997, 179 (12) :4030-4038
[18]   Human rhinovirus 2A proteinase mutant and its second-site revertants [J].
LudererGmach, M ;
Liebig, HD ;
Sommergruber, W ;
Voss, T ;
Fessl, F ;
Skern, T ;
Kuechler, E .
BIOCHEMICAL JOURNAL, 1996, 318 :213-218
[19]   A second-site suppressor strategy for chemical genetic analysis of diverse protein kinases [J].
Zhang, C ;
Kenski, DM ;
Paulson, JL ;
Bonshtien, A ;
Sessa, G ;
Cross, JV ;
Templeton, DJ ;
Shokat, KM .
NATURE METHODS, 2005, 2 (06) :435-441
[20]   Study of second-site suppression in the pheP gene for the phenylalanine transporter of Escherichia coli [J].
Pi, J ;
Chow, H ;
Pittard, AJ .
JOURNAL OF BACTERIOLOGY, 2002, 184 (21) :5842-5847